117th Congress · SENATE BILLBILL

S. 4918 — Increasing Prescription Drug Competition Act

“A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the use of patents, trade secrets, or other intellectual property to inhibit competition.”

Health

Introduced Sep 22, 2022

Last action Sep 22, 2022

Pipeline · Bill → Law

Step 1

Introduced

Sep 22, 2022

Step 2

Referred

Sep 22, 2022

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Sep 22, 2022

Introduced in Senate

Sep 22, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.